−0.0163 USD
−1.05 M USD
120.49 K USD
39.08 M
About BIOMARK DIAGNOSTICS INC.
Sector
Industry
CEO
Rashid Ahmed Maula Bux
Website
Headquarters
Richmond
Founded
2014
FIGI
BBG007WX26J0
BioMark Diagnostics, Inc. is a canadian-based company, which engages in the development and commercialization of cancer diagnostic solutions to detect, monitor, and assess treatment for cancer. The company was founded by Rashid Ahmed Maula Bux on June 19, 2014 and is headquartered in Richmond, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BMKDF is 0.1337 USD — it has increased by 0.53% in the past 24 hours. Watch Biomark Diagnostics Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Biomark Diagnostics Inc. stocks are traded under the ticker BMKDF.
BMKDF stock has fallen by −11.75% compared to the previous week, the month change is a −10.87% fall, over the last year Biomark Diagnostics Inc. has showed a −20.18% decrease.
BMKDF reached its all-time high on Apr 19, 2021 with the price of 0.5083 USD, and its all-time low was 0.0391 USD and was reached on Feb 21, 2019. View more price dynamics on BMKDF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BMKDF stock is 0.52% volatile and has beta coefficient of −0.55. Track Biomark Diagnostics Inc. stock price on the chart and check out the list of the most volatile stocks — is Biomark Diagnostics Inc. there?
Today Biomark Diagnostics Inc. has the market capitalization of 12.61 M, it has increased by 1.61% over the last week.
Yes, you can track Biomark Diagnostics Inc. financials in yearly and quarterly reports right on TradingView.
BMKDF net income for the last quarter is −404.49 K USD, while the quarter before that showed −455.43 K USD of net income which accounts for 11.19% change. Track more Biomark Diagnostics Inc. financial stats to get the full picture.
No, BMKDF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Biomark Diagnostics Inc. EBITDA is −1.34 M USD, and current EBITDA margin is −866.03%. See more stats in Biomark Diagnostics Inc. financial statements.
Like other stocks, BMKDF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Biomark Diagnostics Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Biomark Diagnostics Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Biomark Diagnostics Inc. stock shows the strong sell signal. See more of Biomark Diagnostics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.